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Regular hemodialysis treatment (RHD) in Greece for the period of
1980—1987. G. Papadakis, A. Agrafiotis, A. Katirizoglon, P. Zirog-
hiannis, D. Stamatiadis, N. Kalivretakis, P. Kaloheretis, K. Platsak'is,
B. Dervenjotis, D. Galanis, A. Karaghiannis, A. Bieta, and E. Papa-
dakis. During the period January 1st 1980—December 31st l987, 3371
ESRF patients (pts) (2041 males, 1330 females) were introduced to
RHD in Greece. Their ages ranged from 16 years to 84 years (mean =
53 years), while the underlying renal disease was chronic glomerulone-
phritis in 46%, chronic pyelonephritis in 20%, polycystic disease in 11%
and diabetic nephropathy in 5% of them. The annual number of pts who
initiated RHD increased gradually from 290 in 1980 to 530 in 1987 (53
new pts/million of population). Renal transplantation was performed in
12.5% of all RHD pts, while 3% converted to CAPD and 29.5% died.
The most common cause of death was cardiovascular disorders (60%)
followed by infectious diseases (7%). The cumulative survival rate was
87% at the end of the first year, 55% after 5 years, and 39% at the end
of the 8 year period. By the end of 1987, 2119 pts were on RHD in
Greece (55% in government and 45% in private HD units) of whom 233
had commenced treatment before 1980. Fifteen percent of the pts were
dialyzed with parallel plate and 85% with hollow fiber dialyzers: 95%
followed a 3 sessions/week and 5% a 2 sessions/week treatment
program, while 5.7% were hepatitis B Ag (+). Antihypertensive medi-
cation was deemed necessary for 32% of them; phosphate binding
agents were used by 93%, folic acid and vitamin B complex prepara-
tions by 79% and Fe agents by 47% of all pts. Commitment to RHD
forced 13% of the pts to permanently move from their home, while 24%
of all pts were living at least 30 Km from the unit which they had to visit
for their treatment. Fifty-five percent of all pts were found capable to
continue working on their jobs, 40% were considered unable to con-
tinue working and 5% were unable even to take care of themselves at
home. The results of our study show that the efficiency of RHD in
Greece stays well within the established international standards.
CAPD in Greece. A. Agrafiotis, A. Katirtzog/ou, P. Ziroghiannis, G.
Papadakis, G. Vergoulas, N. Niobros, V. Vervemezis, M. Siakotos, K.
Siamopoulos, A. Dimitriadis, and L. Doumas. During the period
January 1st 1982—August 31st 1987, 555 ESRF patients (pts) (319 males.
236 females) were introduced to CAPD treatment in Greece. Their ages
ranged from IS years to 83 years (mean age = 53 years) and the
underlying renal disease was chronic glomerulonephritis (39%), chronic
pyelonephritis (21%), diabetes mellitus (14%). and polycystic disease
(8%). By the end of August 1987, 301 pts were still on CAPD, 151 had
died. 77 converted to HD treatment and 26 had undergone renal
transplantation. The cumulative survival rate of the pts was 83% by the
end of the first year and 60% by the end of the third year, while the
success of the method was 77% and 45%, respectively. The major
causes of death were cardiovascular disorders (52%). septicemia (11%),
and peritonitis (11%), while the major causes of change of treatment
towards HD were peritonitis (43%), loss of clearance capability of the
peritoneal membrane (28%) and pt's personal preference (11%). One
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hundred and ninety-five pts remained on CAPD for at least 2 years; 36
died, 19 converted to HD, 4 underwent renal transplantation and 136
(70%) of them were still on CAPD by August 3l, 1987. Analysis of the
data concerning the above 195 pts who were treated with CAPD for at
least 2 years showed that: I) CAPD reduces the need for antihyperten-
sive medication: 2) Hypotension is a rare complication in CAPD pts; 3)
Hernias of the abdominal wall are not infrequent; 4) The hernias evolve
usually after the first year of treatment, and usually are located at the
site of surgical incision of the abdominal wall through which the
catheter was implanted (85%) and is more frequent in women (7 1%).
Surgical correction of the hernias is necessary in only half of the cases.
5) Tunnel infection complicates 15% of the cases. The treatment of
choice of this complication is surgical removal of the whole or part of
the catheter. 6) The occurrence of cardiovascular episodes in CAPD pts
has a very poor prognosis, usually fatal outcome (75%).
Renal transplantation in Greece. G. Papadakis, A. Agrafiotis, A.
Antoniadis, G. Vosnides, G. Giagides, D. Grekas, A. Kostakis, A.
B il/is, M. Papadimitriou, N. Papadodimas, M. Pyrpasopoulos, G.
Sakellariou, M. Siakotos, P. Spanos, A. Tourkanionis, B. Hantzikon-
slantinou, 1. Homatas, and E. Papadakis. During the 1968—87 period,
1171 renal transplantations were performed in 1115 Greeks with ESRF.
Adequate information is available for 1113 cases. According to the
available data 651 (58%) transplantations were from living related
donors and 462 (42%) were cadaveric; 758 were performed in Greece
and 355 in other countries. Of the 758 transplantations performed in
Greece 584 (77%) were from living related donors and 174 (23%) were
cadaveric, while of the 355 performed in other countries the figures
were 67 (19%) and 288 (81%), respectively. The cumulative survival
rate of the transplanted pts was 86% after 1 year, 62% after 10 years and
44% after 17 years; the corresponding figures for the graft survival rate
are 67%, 34% and 24%, respectively. In particular, survival rate of the
patients (pis) after living-related donor transplantation was 87% after 1
year, 63% after 10 years and 47% after 15 years compared to those pts
who received a cadaveric graft and whose survival rate was 85%, 60%
and 46%, respectively (P = 0.10). The survival rate of the grafts from
living related donors was 73% after 1 year, 37% after 10 years and 26%
after IS years compared to the cadaveric grafts, in which case the
corresponding figures were 58%, 29% and 23%, respectively (P = 0.01).
One year after transplantation the survival rate of the pts was 87% for
the 1978—82 period compared to 91% for the 1983—87 period (P = 0.10).
The graft survival rate for the same time periods was 62% and 72%,
respectively (P = 0.01).
A study on histogenesis of crescents in glomerulonephritis with mono-
clonal antibodies. L. Nakopoulou,!. Manaligod, L. Ghosh, I. Nikolaou,
Department of Pathology, University of Illinois, Carbondale, Illinois,
USA and Department of Pathology, University of Athens, Athens,
Greece. The expression of two intermediate filament proteins, cytoker-
atins (Ks) and Vimentine (V) was studied in the cells forming the
crescents in glomerulonephritis cases, by the use of monoclonal anti-
bodies in paraffin sections. Our material consisted of 7 cases of crescent
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glomerulonephritis and 11 cases of primary and secondary glomerulo-
nephritis with crescents. Ks were detected in the cells of the glomerular
crescents in 10 of the 18 glomerulonephritis, and the percentage of the
positive cells was 5 to less than 50%. They were also detected in a few
cells of the normal parietal epithelium of Bownan's capsule. V was
reacting strongly in the crescent's cells with a percentage of 30% to
more than 50% in all studied cases, mainly in the cellular crescents. V
had also positive immunoreactivity in many cells of visceral epithelium
and in few parietal cells. From the above result we could conclude that
crescents are of epithelial origin, deriving mainly from visceral epithe-
hum, to a lesser degree from parietal epithelium.
Histocompatibility antigens (HLA-A,B,DR) in Greek patients with
systemic lupus erythematosus (SLE): Correlation with renal involvement.
Chr. Papasteriades, P. Magana, P. Georgiou, M. Maragou, M. Sia-
kotos, N. Nikolopou!ou, F!. Sotsiou, 1. Economidou, P. Dantes, and
A.G. Billis, Division of Nephro!ogy & Pheumatology and Laboratories
of Immunology & Pathology. Evangelismos Hospital, Athens, Greece,
An increased incidence of certain HLA antigens has been reported in
SLE patients (pts) coming from differentethnic groups. However, such
a study has not been done, to our knowledge, in Greek pts. We
therefore studied the HLA antigens in 75 pts (66 females, 9 males), 17
to64 years old, with SLE diagnosed Ito 16 years previously. Forty-five
pts (60%) had evidence of renal involvement (proteinuria > 0.5 g/24 hrs,
microscopic hematuria and/or serum creatinine > I .4 mg%) and in 39 of
them, who had a renal biopsy done, the histological study revealed
diffuse proliferative glomerulonephritis (DPGN) in 23, membranous
glomerulonephritis (MGN) in 8 and other forms of SLE nephritis in 8
pts. The findings of the HLA typing, in comparison to 405 healthy
individuals (controls), are shown below:
Contr.
All
pts
Patients with SLE %
Without
.Wtth RI. (45)
HLA (405) (75) R.1. All DPGN MGN
antig. % % (30) pts (23) (8)
All 9.6 25.3e 263d 24,4d 17.4 25.0
B8 8.9 14.6 10.0 17,7b 13.0 37.S
B18 20.2 28.0 433d ZOO 17.4 0
B35 32.8 37.2 63.3e 20.0 34.8 37.5
DRI 12.3 242b 32.OC 19.5 10.0 0
DR2 44.1 53.0 52.0 53.6 85.Oe 12.5
DR7 16.9 13.6 8.0 17.0 10.0 50.OC
Renal involvement, b P <0.05, C P <0.025, d P <0.01, e P <0.001
These findings suggest a genetic involvement in the pathogenesis of
SLE. In particular: I) The antigens All and DRI correlate with the
susceptibility ofSLE. 2) An increased frequency of B18, B35 and DRI
antigens were found in pts without renal involvement, whereas the DR2
and B8 antigens were more frequent in pts with DPGN and MGN,
respectively. 3) The susceptibility to SLE in the population studied is
expressed through different HLA antigens in comparison to other
ethnic groups.
The significance of the histological scoring system in the prognosis and
treatment of the glomerulonephritis of systemic lupus erythematosus
(SLE). F!. Sotsiou, N. Sklivagou, P. Maggana, D. Kavadias, N.
Nikolopoulou, Gr. Vosnides, AG. Billis. Department of Pathology and
Division of Nephrology, "Evangelismos" Hospital, Athens, Greece.
To evaluate the prognostic significance of histologic lesions, renal
biopsies from 30 patients with glomerulonephritis (GN) of SLE were
studied, using the WHO (1980) classification and the scoring system
proposed by Decker et al (1979), to which we have added vascular
lesions. High activity or chronicity indexes as well high ( 14) and low
(<14) total scores were correlated with serum creatinine levels, blood
pressure and response to treatment. All patients were followed up for 12
to 89 months. Histologically, diffuse proliferative GN (IV) was ob-
served in 19 (63.3%) patients, transformation of one type to another
(mainly V IV) in 6 (20%), membranous GN (V) in 3 (10%) and
mesangial GN (II) in I (3.3%). Chinicopathological correlation revealed
that: I) High total score was associated more often with the develop-
ment of chronic renal failure (P = 0.01). 2) Prominent vascular lesions
were also found more frequently in patients who developed chronic
renal failure (P < 0.05). 3) The high chronicity index showed strong
correlation with an increase in serum creatinine levels, despite therapy
(P <0.01) while high activity index was associated with better response
to therapy and reduction in serum creatinine levels (P < 0.05). These
observations suggest that, in planning the treatment and determining
the prognosis of patients with SLE and renal involvement, the semi-
quantitative evaluation of the renal lesions is more helpful than the
assessment of the histological type alone.
Intermittent cyclophosphamide i.v. bolus in persistent forms of lupus
nephritis: Preliminary results. G. E. Digenis, N. Kallivretakis, I. Ka-
kavas, E. Grapsa, 0. Arvanitis, K. Potamitis, and N. Zerefos, Nephrol-
ogy Depart,nent of Athens Hippokration Hospital, Athens, Greece. The
goal of this study was to evaluate the influence, if any, of monthly i.v.
bolus cyclophosphamide (CP) administration in persistent forms of
lupus nephritis. Five female patients (pts), age range 19 to 41 (5: 27)
years, who had been unsuccessfully treated with corticosteroids and/or
cytotoxic drugs for at least 3 months, were selected. The duration of
their disease was I to 18 (: 7) years. Four pts had membranoprolifer-
ative and the fifth had membranous glomerulonephritis. Mean creati-
nine clearance was 41(8 to 84) ml/min/I.73 m2. A CP dose of I g/l.73
m2/month was infused i.v. During and 2 hours following the infusion the
patient's scalp was protected by means of a special head covering with
a cooling system, in an attempt to avoid alopecia. All pts received
methylprednisolone concomitantly 8 to 16 mg/day. A total of 13 boluses
were administered. They were all tolerated very well and we have not
observed alopecia, leucopenia or cystitis in any patient. Edema de-
creased significantly in all pts along with hypertension, and the dose of
antihypertensive medications had to be lowered. Proteinuria has signif-
icantly diminished, while GFR, C3 and,C4 levels have increased.
Antinuclear antibody levels were reduced in 3 cases, but anti-DNA
titers remained unchanged. These results suggest that the monthly i.v.
bolus of CP: a) is an effective treatment for persistent forms of lupus
nephritis where other modes of treatment have failed; and b) it allows a
reduction in the dose of corticosteroids which could lead to a reduction
of their side effects.
Plasma exchange (PE) in the treatment of lupus nephritis. G. Sakella-
rioii. P. Koukoudis, T. Natsche, D. Memmos, and M. Papadimitriou.
Renal Unit. Hippokratio Hospital, Thessa!oniki, Greece. Since 1983, 9
patients with diffuse proliferative lupus nephritis resistant to conven-
tional immunosuppression have been treated with PE. The mean
number of PE sessions was 12 and the mean plasma volume exchanged
per session was 2.5 liters. For the evaluation of the results, apart the
clinical and biochemical parameters before and after PE, we measured
complement components (C3, C4, FB), circulating immunocomplexes
(IC), antinuclear and anti-DNA antibodies and lymphocyte subpopula-
tions in the peripheral blood (OKT3, OKT4, OKT8, ratio OKT4/
OKT8). The mean values of urea and creatinine were 1.8 g% and 7.0
mg%beforePE and 0.8 g% and 2.0 mg% after PE. Anti-DNA antibodies
decreased significantly after treatment(125 58 vs. 62 35)as well as
antinuclear antibodies and IC. In 4 patients, C3 and C4 levels increased
rapidly within normal range after treatment. Renal function became
normal in 6 patients. Three patients did not respond to PE and reached
finally end-stage renal failure.
Plasma osteocalcin (BGP) in hemodialyzed patients receiving vitamin
D3. A. Patrikarea, J. Papadakis, J. Malamitsi, K. Kalogeropoulou, J.
Kirousis, J. Mitsis, Th. Theodorides, N. Papadoyannakis, K. Koutou-
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lidis, and S. Vafiadis, Renal and Nuclear Medicine Department of
NIMTS Hospital and Department of Mineral Engineers qf National
Technical University ofA thens, Athens, Greece. Plasma BGP increases
significantly in chronic renal failure (CRF). BGP was measured by
radioimmunoassay. We studied its correlation with c-terminal frag-
ments of parathyroid hormone (1PTH), intact PTH (iPTH-int). calcito-
nm (iCT), serum alkaline phosphatase (ALP). calcium (Ca) and phos-
phate (P), in 13 patients of different stages of CRF (group I) and in 30
uremic hemodialyzed patients (HP) (group II). In the latter we also
measured the ratio (R) of 99 mTc-MDP intake of the lumbar spine and
the serum aluminium with the atomic absorption method. The patients
in this group were treated for 8 months with low doses of laOH-D3
(0.25-0.75 j.tg/day). Plasma BGP was increased in both groups: group 1
(13.17 7.97 nglml), group 11(83.89 71.45 ng/ml). normal values (4.8
2.23 nglml). In group I BGP was positively correlated with 1PTH (r =
0.768; P < 0.01) but no correlation was found with the rest of the
parameters. In group II BGP was positively correlated with iPTH (r =
0.482; P < 0.01), iPTH-int (r = 0.570: P < 0.02). ALP (r = 0.497: P <
0.05)but not with iCT, Ca. P and R. The latter was positively correlated
with iPTH (r = 0.582; P < 0.02) as well as with iPTH-int (r = 0.746; P
<0.01). Serum Al was found to be 64.36 43.72 zgIliter. We conclude
that low doses of laOH-D3 do not restore the BGP values in HP. We
also indicate that plasma BGP is a very reliable index of secondary
hyperparathyroidism of uremic patients before and after their enroll-
ment in dialysis treatment.
Radionuclide evaluation of calcium kinetic parameters in HD and
CAPD patients with secondary hyperparathyroidism. P. Kurz, T. Tsoha-
nelis, U. Ei'ald, E. Werner, P. Roil,. and J. Vlacl,ojannis, St. Markus-
Krankenhaus, Ges .f Strahlen- u. U,nu'eltftnschung, Frankfurt/Main.
Federal Republic of Germany. Irrespective of the method of dialysis
applied (HD or CAPD), renal osteopathy shows progression. The
pathophysiological processes in the disturbed calcium-parathormone
(PTH)-feedback regulation system could not be clarified completely. In
CAPD- (N = II) and HD patients (N = 12). the calcium absorption
(Ca-ab) (vitamin D dependent), Ca retention (Ca-ret) and Ca clearance
(Cca; both PTH dependent) were investigated with 2 radioactively-
labeled calcium isotopes (45Ca p.o.: 4Ca i.v.) and the results were
compared. The hyperparathyroidism was defined by clinical chemical
and histological parameters.
Ca ion Ca
,nval/liter
PTH
pmol/l
Vit. D
pg/I
Ca-ab
% c
Ca-ret
%
CAPD 4.5 l.9 15.3 23.8 42.4 2.5 25.4
HD 4.6 1.9 33.2 20.3 47.3 3.4 35.1
P NS NS <0.05 NS NS <0.01 NS
In accordance with the higher PTH concentration, the Ca clearance was
significantly higher in the HD than in the CAPD patients. In addition, a
positive correlation between PTH concentration and Ca retention could
only be shown in the HD patients. No significant differences were found
between the two groups in the further parameters of calcium kinetics.
These results indicate an adequate adaption of Ca kinetics to PTH
secretion in the HD patients, whereas the CAPD patients display a
calcium retention which does not depend solely on the serum PTH
concentration. Consequently, an "escape phenomenon" must be as-
sumed as an explanation for the PTH effect on bone metabolism in
CAPD patients.
Renal osteodystrophy evaluation by quantitative computed tomogra-
phy. K. Siamopoulos, A. H. Karantanas, J. Kalef-Ezra, G. Sfl,ero-
poulos, A. Halla, P. Katsiotis, D. Glaros, Departments (1Medical
Physics and Radiology, Medical School, University of Joannina; Dc-
partineni ofNep/,rology, 'G. Hatzikosta" General Hospital, loannina,
Greece. The evaluation and follow-up of renal osteodystrophy by
non-invasive methods is of high clinical importance. The aim of this
study was to evaluate the bone mineral density (BMD) in chronic renal
failure patients, using quantitative computed tomography (QCT). A
modified version of the Cann-Genant QCT technique was applied and
the BMD vertebral T,.,, 0,, 02, 03 trabecular bone was estimated.
Sequential measurements in humans and phantoms and dosimetric
studies showed that both good precision (C.V. --2%) and relatively low
radiological risk (5 to l0') were achieved. Ninety-two patients were
studied: IS with severe chronic renal failure (serum creatinine 4 to 10
mg/dl). 14 renal graft recipients with adequate renal function, 8 on
CAPD, and 55 on chronic maintenance hemodialysis. Among them 80%
had significantly lower BMD than age- and sex-matched controls, while
10% had significantly higher BMD. Graft recipients studied before and
after grafting showed a significant reduction of BMD shortly after
transplantation. Whereas the QCT technique does not provide informa-
tion on the type of histological bone lesions, it allows the precise
determination of long term changes in BMD in the tissue with the
highest turnover. This technique in conjunction with y-photodensitom-
etry and in vivo partial body neutron activation analysis is used for
following up our patients.
Renal osteodystrophy in patients undergoing CAPD for more than five
years. G.E. Digenis. NB. Dombros, K. Sombolos, H.E. Meema. and
D.G. Oreopoulos, Peritoneal Dialysis Department of Toronto Western
Hospital, Toronto, Canada. Osteodystrophy increases the morbidity of
the patients (pts) treated by any kind of dialysis. Twenty pts (12 men
and 8 women aged 49 3.3 years. SEM) undergoing CAPD for 5 to
10 years were studied. Five of them were diabetics. Dialysate calcium
was 6 mg/dl and the mean daily calcium intake was 500 mg. Aluminum
hydroxide was the main phosphate binder, and vitamin D or
I .25(OH)2D2 were given in doses sufficient to maintain serum calcium in
normal limits. Pts were divided in two groups according to the radio-
logical findings at the beginning of treatment. Group A (9 pts) included
those who had no subperiosteal resorption (SPR) and group B (II pts)
those with SPR at the initiation of CAPD. Only 3 pts of group A
maintained a normal index of SPR; the rest (6) had a progressive
increment of it. In group B, 7 pts presented an aggravation, 2 pts
maintained the same levels and only the final 2 had an improvement of
their SPR index by the time. Extraskeletal calcifications (usually
arterial) were present mainly in diabetics during the first 5 years of
CAPD. but they also developed and progressed in 7 non-diabetic pts
afterwards. Six pts of group B developed 9 spontaneous fractures which
were healed. Seven bone biopsies (2 in group A and 5 in group B)
presented mainly osteomalacia with positive aluminum stain in group A
and predominant findings of hyperparathyroidism in group B. In con-
clusion. hyperparathyroidism persists in pts maintained on CAPD for
more than 5 years. This may be attributed to a low dialysate calcium
and low oral calcium intake.
Neck ultrasound for diagnosis of secondary hyperparathyroidism (SH)
in 125 patients on chronic hemodialysis (CH). D. Mourikis, N. Papado-
yannakis, A. Antonio,,, K. Perakis, S. Moutafis, and L. Vita. One
hundred and twenty-five patients on CH (duration from 2 months to 13
years) were investigated with neck ultrasound for the establishment of
the diagnosis of SH and for localization of the parathyroid nodules. In
34 the ultrasounds were positive for enlarged parathyroid glands (27%).
The percentage of the positive results were related with the duration of
CH treatment as follows: from two months to I year 14%, from 1 to S
years 17%, from 6 to 10 years 38%, and from II to 13 years 90%. In the
34 patients with positive results 54 nodules were detected. In 3 patients
3 enlarged nodules were detected, in 14, 2 and in the remaining 17 one
nodule was recorded, respectively. The size of the nodules was in 21
from 5 to 10 mm diameter. In another 21 from II to 15, inS from 16 to
20 and in 7 from 21 to 25 mm. Multiple linear regression analysis of the
duration of CH and the degree of bone changes showed a strong
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relationship. In 4 out of the 34 thyroid nodules were detected as well.
whereas in 91 with negative ultrasound parathyroid findings 19 were
found with thyroid nodules. In 6 patients who underwent partial
parathyroidectomy ultrasound findings were confirmed surgically.
Surgical management of secondary hyperparathyroidism: experience
with 110 cases. G. Kapellakis, D. Koutsikos. G. Kekos. A. Tsinakis, G.
Androulakis, 2nd Surgical Department, University of Athens, Are-
taieon Hospital, Athens, Greece. Between April 1976 and October
1987, 110 patients underwent subtotal or total parathyroidectomies as
therapy for secondary hyperparathyroidism. All patients failed to
respond to prior medical treatment with vitamin D and phosphate
binding antacids. Criteria for surgery included one or more of the
following: I.) radiographic evidence or clinical signs of hyperparathy-
roidism; 2.) metastatic calcification: 3.) severe pruritus: 4.) hypercalce-
mia; 5.) hypercalcemia after renal transplantation. All patients tolerated
the operation extremely well. There was no operative death. Postoper-
atively the majority of our patients showed significant clinical improve-
ment. Parathyroidectomy was of questionable value in other patients
while the clinical status in 10 patients was not altered by this procedure.
In this series the best results were obtained in patients with severe
clinical manifestations of hyperparathyroidism. high level alkaline
phosphatase and with soft tissue calcification.
Early complications and long-term sequelae of the subclavian hemodi-
alysis catheter and their prevention. D. Kavadias, Gabr. Papadakis,
Chr. Oikonomopoulou, P. Sarantakis, and N.H. Papadodimas, Dc-
partment of Nephrology, Tzanion General Dept.. Hospital Pireas,
Greece. During the last 18 months we have placed 87 subclavian
hemodialysis catheters (SHCs) in 76 patients. The SHC remained in
place from 2 to 50 days (mean 16.7 I days) and a total of 600 dialyses
was performed (range I to 22). The SHCs were inserted only by
designated nephrologists, and trained nurses took care of them. All
SHCs were removed and cultured by a semiquantitative culture tech-
nique. Immediate complication was one hemothorax. Catheter-associ-
ated bacteremia occurred in 3 patients (av. 3.45%). Seven more SHCs.
while not clinically infected, were culture-positive (av. 8.05%). The
nine SHCs inserted over a guidewire to replace malfunctioning or
clotted SHCs were culture-negative. We performed subclavian veno-
gram in 10 asymptomatic patients 2 to 16 months after the removal of
the SHC. One patient had slight stenosis of the right and another severe
stenosis of the left subclavian vein. Seventeen months after the removal
of the SHC the latter became symptomatic. Our results indicate that
under the appropriate conditions, with a dialysis team carefully trained.
we can substantially reduce the immediate complications related to the
SHCs and the catheter-associated infections. Nevertheless, late subcla-
vian vein thrombosis may compromise access sites in the ipsilateral
arm.
Survival and physical rehabilitation of patients undergoing chronic
hemodialysis (CH) for 10 years or more. G. Papadakis, N. Germanos,
N. Papadodimas, V. Hadjikonsiantinon, Gr. Vosnides, G. Psi,nenos,
andA.G. Billis, 1st Department of Medicine, General State Hospital (1
Athens. Is, Department ofPropedeutic Medicine, University ofAthen.s,
and Laiko' General Hospital, Athens, Greece. In the last few years
there have been occasional reports on the survival and the quality of life
of patients (pts) with end-stage renal failure who were treated by CH for
10 years or more. Since there are no similar observations in a consid-
erable number of Greek patients (pts). we retrospectively analyzed 286
successive pts, 16 to 70 years old, who were put on Cl-I from January
1970 to December 1977 and were subsequently followed until either
their death or December 1987. Eighty-five of these pts received a renal
transplant from a living (46 pts) or cadaveric (39) donor, while the
remaining 201 pts with a mean age 45.2 years were treated only by
dialysis. Forty-four of these 201 pts (22%). survived for 10 years or
more and 31 of them were still living at the end of the follow-up period.
that is for 124 to 212 months. The cumulative survival rate (calculated
by the Cutler-Ederer method. 1958) at the end of the first decade was
22%. All pts but one, who survived more than 10 years, were 55 years
of age when they were put on CH. During the CH treatment. II of the
31 pts (35%) had a parathyroidectomy. 7 pts (22.6%) developed carpal-
tunnel syndrome and 5 pts (15%) pericarditis. At the end of the
follow-up period 13 pts (42%) were working or were able to work, while
the remaining 198 (58%) had significant disability problems (angina,
carpal-tunnel syndrome,joint or bone pains etc.) and they were not able
to work (II pts) or even to look after themselves (7). These observa-
tions suggest that the survival of our pts by CH alone beyond the first
10 years is favorably compared with that reported in the literature, but
the physical rehabilitation in the majority of these pts was not satisfac-
tory.
Immunoglobulin class detection and antibody specificity in immunized
renal transplant candidate recipients. M. Var/a, M. Papanicolaou. P.
Douramani, D. Scoumi, and C. Stavropoulos, Immunology Depart-
,nent, National Tissue Typing Lab. The knowledge of antibody speci-
ficity of immunized kidney patients is essential for their characteriza-
tion as proper recipients for renal transplantation, given that some
antibodies are not prohibitive for transplantation (ex-lgM autoantibod-
ies). Detection of the antibody type was attempted in 30 immunized
patients. Sera were tested using the lymphocytotoxic assay (CDC)
against PBL and B lymphocytes of 30 donors and specifically: a) at 4°.
18°. 37°C for warm and cold reacting anti-T and -B antibodies's
detection: b) using Dithiothreitol (DTT) for 1gM reduction: c) using a
monoclonal anti-H LA class 1 antibody for cytotoxic inhibition of
anti-HLA class I antibodies: d) after treatment with NaCL at 70°C as
well as against CLL cells for autoantibodies' detection. Results are: A)
24 sera (80%) had anti-T and -B warm reacting lgG Abs; B) 2 sera
(6.6%) had anti-B warm IgG Abs; C) I serum (3.3%) had anti-B 1gM
Abs; D) I serum had anti-B 1gM non-anti-HLA autoantibodies: E) 2
sera (6.6%) had anti-T and -B igG non-anti-HLA autoantibodies.
According to these results and bibliographical data, C and D category
patients are not excluded from transplantation even with a positive
cross-match. Although the percentage of these patients is low (6.6%), it
dictates the necessity to determine the candidate recipients' antibody
specificity for a proper selection in renal transplantation.
HLA-A,B,DR "superhaplotypes", mixed lymphocyte culture and kid-
ney graft survival from a haploidentical living-related donor. M. Danii-
lidis, Z. Polvmenidis, G. Sakellariot,. E. Papakyriazi, K. Adam, and M.
Papadimnitrion. Immunology & Histocompatihilitv Depart,nent, Hip—
pokration Hospital of Thessaloniki, and Nephrology Department. Hip-
pokration Hospital. Aristotelian University of Thessaloniki, Thessalo-
niki. Greece. The significance of compatibility in HLA-A,B haplotypes
with increased in the Greek population was first reported in kidney
transplantation from a haploidentical living-related donor (HLRD), in
1981. HLA-A.B.DR "superhaplotypes' (SH) or "supratypes", such
as AIB8DR3. A2BI2DR2. AIIB5DR4. AIIB35DR4, A3B7DR2 and
A9BI2DR4. were studied as to their significance in clinical renal
transplantation. From June 1984 to June 1987, 41 patients received a
kidney graft from a HLRD. parent or sibling, in all 41 pairs mixed
lymphocyte culture (MLC) were performed. The MLC stimulation
index was <3 in 21 of4l recipients (group a) and >3 in the remaining 20
(group b). During the first 3 months after transplantation, 8 rejection
episodes were observed in group b, while only 2 in group a (P < 0.05).
Average creatinine values 12 months after the transplantation were 1.93
0.73 and 1.35 0.42 mg%. respectively (P < 0.005). Mean values of
the stimulation index in the SH-compatible MLC were 2.1 0.52 while
4.61 1.39 in the SH-incompatible MLC. Our results suggest that
matching for HLA-superhaplotypes. which are usually encountered in
the Greek population, increases the graft survival of haploidentical
grafts in related kidney allotransplantation.
Antibody responses to certain viruses by cyclosporine-immunosup-
pressed allograft recipients. Analysis of 206 renal transplant recipients. S.
Drakopoulos, D.J.G. White, Sir R. Y. Caine, T.G. Wreghiti, JR.
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Walker, and C.E.P. Taylor, Department of Surgery University of
Cambridge, and Clinical Microbiology and Public Health Laboratory,
Addenbrook's Hospital Cambridge, Cambridge, England, United
Kingdom. The immunosuppressive agent cyclosporin A (CsA) is report-
edly relatively ineffective at suppressing antibody responses. The
antibody responses to cytomegalovirus (CMV), herpes simplex virus(HSV), Epstein-Barr virus (EBV), and rubella (HI) were studied
longitudinally for up to five years in 206 renal transplant recipients
immunosuppressed with cyclosporin A. Results record substantial
antibody responses against EBV, HSV, and CMV. Our data demon-
strate that in this almost unique patient population, significant numbers
of recipients are reactivating both CMV and EBV within the first year
post-transplant. The fundamental observation reported here is that
despite CsA immunosuppression these patients are able to produce
significant antibody responses to this viral reactivation. This was
irrespective of the organ transplanted. Somewhat, surprisingly, our
patients were also able to mount significant antibody responses to
primary viral infection as well as reactivation. No correlation between
antibody titer increases and the clinical condition of the patient could be
found. The majority of antibody increases occurred in the first year
post-transplant. A high incidence of primary CMV infection was
demonstrated in the early post-transplant phase, suggesting that this
was as a result of infection from the donor organ. These studies
demonstrate that immunosuppression with CsA does not prevent anti-
body responses to viral infections.
Renal ischaemia combined with acute cyclosporin toxicity in dogs; the
effect of preventive administration of verapamil. P. Anassis, E. Alexo-
poulos, E. Tzamou, E. Theodoridou-Fragouli, and M. Papadimitrioti,
2nd Prop. Department of Internal Medicine, Hippocration General
Hospital, Aristotelian University of Thessaloniki, Thessaloniki, Greece.
Cyclosporin A (C5A) is incriminated as an important risk factor for the
appearance of postoperative acute renal failure in transplanted patients.
To evaluate the protective role of verapamil on this complication, a
combined model, as seen in clinical practice, of both renal ischemia (30
mm) and i.v. administration of CsA was studied in 20 mongrel dogs.
Both kidneys of each dog were exposed by bilateral flank incisions. The
renal pedicle of one kidney (control) was initially clamped and 0.5 mgI
kg of body weight of verapamil were given iv. Five minutes later, the
renal pedicle of the other kidney (Ve-kidney) was also clamped. During
the ischemic period CsA was given i.v. in a total dose of 5 mg/kg of
body weight. Renal function was studied for 2 hours after revascular-
ization. The analysis of the data showed: l)The mean time initiation of
diuresis was 44.99 9.66 mm for the Ve-kidney and 54.95 5.73 for the
control group (P < 0.05). 2) The Ve-kidney group also had significantly
higher creatinine and urea clearances (P < 0.005), and osmolality
clearances (P < 0.05). 3) The mean value of FeNa in the Ve-kidney
group was significantly lower during the first 10 periods (P < 0.05). 4)
There was no difference between the mean urinary concentration of
LDH in our groups. It is therefore likely that the administration of
verapamil has a favorable influence on the course of ischemic-CsA ARF
in dogs, possibly due to the prevention of vasospasm related with CsA.
Is cyclosporin G more or less nephrotoxic than cyclosporin A. S.
Drakopoulos, R. Y. Caine, D. White, K. Rolles, D.Mc Naughton, S.
Winter, and S. Thiru, Department of Surgery, University f Cambridge,
Cambridge, England, United Kingdom. NVA2 cyclosporine (CsG) is an
analogue of cyclosporin A (CsA) in which the alpha-amino buturic acid
residue in position 2 has been replaced by Nor-valene. It has been
reported that CsG is less nephrotoxic to hypertensive rats than CsA,
although the degree of toxicity has been questioned. We have tested
CsG for its immunosuppressive activity and relate it to blood levels
achieved. We report here a detailed comparison between CsG and CsA
in mongrel dogs with kidney allografts. There was no significant
difference in renal function assessed by serum creatinine or urea
between the two groups. However in four animals in the CsA group
which died during the high dose period, renal histology revealed fine
isometric vacuolation of the epithelium of the descending proximal
tubules, resembling the lesion associated with CsA nephrotoxicity on
man and animals. No such vacuolation was seen in the CsG group. The
apparent superior absorption from the gastrointestinal tract of CsG
compared with CsA and the possibility that is not nephrotoxic in
immunosuppressive doses may both be important clinical advantages.
Analysis of 138 multiple organ donors: Technique and fate of kidney
grafts from these donors. S. Drakopoulos, N.Y. Jamiemson, K. Rolles,
andSir R. Y. Caine, Department of Surgery, University of Cambridge,
Cambridge, England, United Kingdom. Over a six year period (1979—
1985) we have harvested organs from 138 multiple organ donors, We
present our current technique and the results of grafting of 74 kidneys
removed from such donors. Eighty-four donors were male (range 2 to 60
years, average 24.3 years) and 54 female (range 7 to 58 years, average
27.9 years). In all cases donors were brain dead, ventitated, and heart
beating, circulation being maintained until the moment of organ re-
moval. Four hundred and forty-six organs were harvested from these
138 donors with six different combinations: pancreas, heart and kidneys
3 cases; heart, liver and kidneys 15 cases; liver and kidneys 90 cases;
pancreas, liver and kidneys 12 cases; pancreas+kidneys 17 cases; liver,
pancreas, heart and kidneys One Case. Cause of death, blood group and
country of origin have been analyzed. Seventy-four kidneys removed
from 52 of these donors were transplanted in our own center, and we
have further analyzed the details of these donors and the subsequent
fate of these kidneys: immediate function 74.4% (55 patients); delayed
function 22.9%(17 patients); non-function 2.7%(2 patients). Of these 74
recipients 87.8% (65 patients) had a functioning graft on discharge from
the hospital. This study shows the excellent outcome of kidneys
removed from such multiple organ donors.
Immunosuppression in kidney transplant patients: Correlation between
two regimes. G. SakeIlariou, E. Alexopoulos, M. Daniilidis, E. Koko-
lina, 0. Liamos, T. Natshe, M. Papadimitriou. The efficacy of two
immunosuppressive regimes was evaluated in 2 groups of transplant
patients. Group A was given conventional immunosuppression (meth-
ylprednisolone EMPI and azathioprine [Aza] and Group B triple drug
immunosuppression (Mp, Aza and Cyclosporin A). Group A consisted
of 67 patients with a mean age of 35 years. In 49 patients (73%) the
grafts came from living related donors (LRD) and in 18 (27%) from
cadaveric donors (CD). Group B consisted of 58 patients with a mean
age of 34 years. Forty-one grafts (71%) came from LRD and 17 (29%)
from CD. Acute rejection was diagnosed in 41 patients of Group A and
22 patients of Group B (P < 0.001). Fifteen days after transplantation,
mean Pcr (±sD) was 1.48 0.79 mg% in Group A and 1.90 1.1 mg%
in Group B (P < 0.05). Mean Pcr at last follow-up was 2.1 1.28 mg%
in Group A and 1.8 0.82 in Group B (P = NS). Actuarial graft survival
after 2 and 4 years was 68 and 51% in Group A and 94 and 64% in Group
B. respectively. Patient survival for the same period of time was 95 and
89% in Group A and 100 and 93% in Group B. Graft loss due to rejection
occurred in 22 patients of Group A (33%) and 8 to Group B (13.7%) (P
< 0.001). In conclusion, triple drug immunosuppression seems to be
superior regarding graft survival and rejection frequency.
Triple (cyclosporin (CsA) + azathioprin (AZA) + methylprednisolone
(MP) and double (CYA + MP) immunosuppressive therapy schemes in
renal transplants from cadaver donors. A comparative study. J. Ho-
matas, A. Kostakis, S. Kyriakidis, G. Zavos, S. Garbis, I. Koulen-
lianos, D. Kiriaki, C. Zerva, M. Siakotos, V. Hatzikonstantinou, V.
Alevizou, and A. Billis, Transplantation Unit, General Laiko Hospital,
Athens. Greece. Double and triple therapy schemes were compared in
SI patients (35 males, 16 females) receiving cadaver kidney transplants.
Thirty-five patients, aged 45.6 11.02 years (SD) and 2.57 0.81
common antigens with the donor received double therapy (Group I),
and 16 patients of mean age 43.9 10.8 years and 2.81 0.98 common
antigens received triple therapy (Group II). Starting CsA dose for
Group I was 10 mg/kgI24 hrs and thereafter whole blood levels were
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maintained at 500 to 1000 ng/ml. MP was given I g immediately at
operation and then 20 mg124 hrs, with reduction after 3 months. In
Group II CsA was given at 8 mg/kg/24 hrs with maintainance levels 150
to 300 ng/ml and MP reduced to 10 mg/24 hrs by the end of the first
month; AZA was given 2 mg/kg/24 hrs and reduced if marrow suppres-
sion occurred. One and two year survival in Group I was 89% and in
group!! 100% (P >0.1 log rank test). One year graft survivals were 69%
and 100% for group 1 and II (P < 0.05). In conclusion, triple therapy
improves graft survival and requires smaller doses of CsA and MP.
Results of double (cyclosporin (CsA) + methyiprednisolone (MP) and
triple (Csa + MP + azathioprin-AZA) immunosuppressive therapy in 81
recipients of kidneys from living related donors (LRD). J. Homatas. A.
Kostakis, S. Kyriakidis, K. Megalokonomos, Th. Viassis, J. Alexo-
poulos, I. Koulentianos, D. Kiriaki, M. Hatzikonstantinou, M. Sia-
kotos, V. Alevizou, A. Stavropoulou, and A. Billis, Transplantation
Unit, General Laiko Hospital, Athens, Greece. Double and triple
immunosuppressive therapy schemes were compared in 81 recipients of
LRD kidneys (64 males and 17 females, aged 34.6 10.3 years).
Forty-seven formed group I (triple therapy) and 34 group II (double
therapy). Group I received CsA 8 mglkg/24 hrs initially and thereafter
whole blood levels of 150 to 300 ng/ml were maintained. One g MP was
given stat and from 20 mg124 hrs reduced to 10 mg124 hrs by 30 days.
AZA 2 mg/kg/24 hrs was reduced according to bone marrow suppres-
sion. In group II CYA dose was 10 mg/kg/24 hrs initially then to
maintainance levels of 500 to 1000 ng/ml. MP was the same as in group
I but was reduced after 3 months. One and two year patient survival
was 100% for group I and 82% and 75%, respectively in group II (x2 =
9.5; P <0.01 log rank test). One and two year graft survivals were of the
same order 97% for group I and 52% and 42% in group II ( = 25.21;
P < 0.001 log rank test). Triple therapy ensures better patient and graft
survival and requires smaller does of CsA and MP, resulting in lower
cost and fewer side effects than does double therapy.
Radioisotopic evaluation of renal transplant complications. A. Stat'-
raka-Kakavaki, D. Koutsikos, E. Vlonjou, N. Benetsanakis, and D.
Apostolopoulos, University of Athens, Areteion Hospital. Nuclear
Medicine Department and Nephrologic Center of University f Athens,
Areteion Hospital, Athens, Greece. Eighty-six patients, aged 7 to 64
years, who had undergone renal transplantation were studied prospec-
tively. Scintigraphic data were obtained and analyzed by a computer-
assisted y-camera. Tc99m-DTPA dynamic renal scan was performed in
all patients, while Tc99m-DMSA quantitative scintigraphy was addi-
tionally used in selected cases. With these radioisotopic techniques, by
a simple non-invasive method, reliable information was derived (sensi-
tivity 92%, specificity 78%) concerning: a) perfusion abnormalities
(renal artery stenosis, renal vein thrombosis); b) urologic complications
(urine extravasation, urinary tract obstruction, etc.: C) acute rejection:
and d) chronic rejection. Dynamic imaging with Tc99m-DTPA was
found sufficient in the evaluation of (a) and (b) complications, while
complementary quantitation of renal graft function with Tc99m-DMSA
proved valuable in the latter two cases.
Genetic factors and immunization of CRF patients after blood transfu-
sion. M. Papanicolaou, M. Varla, P. Douramani, C. Stavropoulos,
Immunology DP, National Tissue Typing Lab. The reason some people
develop alloantibodies and others don't after transfusions is still an
unsolved question. As the immune alloreactivity may be caused by
genetic factors, we looked for possible associations between immuni-
zation and sex, blood group and the DR phenotype of immunized
patients. Three hundred and thirty-four patients were studied (146
females and 188 males); 106 of them were immunized (3 1.73%). The
percentage was higher in women (36.30% vs. 28.19%) but not statisti-
cally significant. No association was found between blood group and
immunization. The frequency of HLA-DR, was higher in immunized
patients than in non-immunized (40.5% vs. 31.5%). Especially in the
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male group the difference was statistically significant (P < 0.05).
Patients immunized after one or two units of blood possessed the
HLA-DR3, in higher frequency than the non-immunized (39.1% vs.
15.0% P < 0.001) in contrast to the multi-transfused patients, where
there was no significant difference. Conclusively, it seems that DR2,
especially in association with XY gene, is involved in the development
of cytotoxic antibodies (Jr gene?) while DR3 (known as a gene of
increased immune activity) predisposes the ability of immunization
after antigenic stimulation with a small number of transfusions.
The role of blood transfusion on cell mediated immunity in patients on
chronic dialysis. D. Tsakiris, J.D. Briggs, M.A. Watson, and B.J.R.
Junor. Renal Unit, Western Infirmary, Glasgow, Scotland, United
Kingdom. It has been suggested that cell mediated immunity (CMI) may
improve in patients who are on CAPD and this could be detrimental to
transplant outcome. We assessed the CMI of 92 CAPD and 368 HD
patients using the dinitrochlorobenzene (DNCB) skin test. In both
groups the number of blood transfusions (BT) was inversely correlated
with the response to DNCB (P < 0.005 and P < 0.001, respectively).
The difference in strong DNCB responders between CAPD and HD was
not significant in patients immunized to DNCB prior to any BT (50% vs.
63%) or in those immunized after one or more BT (29% vs. 24%).
Follow-up tests in the former CAPD and HD patients showed a
significant increase in the DNCB scores in both groups, whereas in the
latter patients there was no significant change. Since BT requirements
in CAPD are less compared to HD It is likely that differences in CMI
may be BT-induced. To support this, we examined CMI alterations
induced in 10 previously non-transfused CAPD and 17 HD patients by
5 to 10 units of elective BT over a period of 3 to 6 months. A protein A
plaque assay showed no difference in the degree of suppression of IgG
secreting cells after stimulation with pokeweed mitogen which depends
on suppressor cell activity. This suggests that BT-induced suppression
is comparable in CAPD and HD patients and that CMI responses may
not improve on CAPD when the BT effect is excluded.
Panel reactive antibodies (PRA) after elective pre-transplant blood
transfusion. A prospective randomized study. D. Tsakiris, J.D. Briggs,
and B.J.R. Junor, Renal Unit, Western Infirmary, Glasgow, Scotland,
United Kingdom. The cell mediated immunity of 48 non-previously
transfused dialysis patients was measured using the DNCB skin test.
There were 21 weak and 27 strong responders. These patients were
randomized to receive 5 or 10 units of elective third party packed cells
in preparation for transplantation. The development of cytotoxic anti-
bodies (PRA) was measured after each blood transfusion and for up to
32 months thereafter. The overall sensitization rate using the last sera
after 5 and 10 units of blood was 20% (6 of 30) and 39% (7 of 18),
whereas the sensitization in historical sera was 27% (8 of 30) and 44%
(8 of 18), respectively. The sensitization rate using the last sera after 5
units in the weak and strong DNCB responders was 15% (2 of 13) and
24% (4 of 17), whereas after 10 units it was 25% (2 of 8) and 50% (5 of
10), respectively. These differences were not significant, but both the
rate and level of development of PRA in weak DNCB responders were
comparable to those of the strong DNCB responders only after the fifth
transfusion. After the third unit of blood none of the 21 weak DNCB
responders had developed PRA compared to 22% (6 of 27) of the strong
DNCB responders. Thirty-two of the 48 patients were subsequently
transplanted, and the best graft survival was observed among the
patients who were transplanted against zero PRA in both historical and
pre-transplant sera. Transplants with historical positive PRA but neg-
ative or declining pre-transplant PRA had also successful transplants,
whereas the 3 patients transplanted against a non-declining >30% PRA
in both historical and pre-transpiant sera lost their graft. Finally,
post-transplant sensitization with >30% PRA in 5 previously non-
sensitized patients was associated with irreversible rejection.
Tests of delayed type hypersensitivity in a prospective controlled study
of the blood transfusion effect in chronic dialysis patients. D. Tsakiris,
and J.D. Briggs. Renal Unit, Western Infirmary, Glasgow, Scotland,
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United Kingdom. We studied 60 previously non-transfused chronic
dialysis patients, 48 of whom were allocated to receive 5 third-party
blood transfusions (BT), 18 patients received 10 BT and the remaining
12 were used as controls. The cell mediated immunity of these patients
was measured using the dinitrochlorobenzene (DNCB) skin test and 4
recall antigens (PPD, mumps, Candida, streptokinase). The aim of the
study was to see whether BT-induced alterations in CMI could be
monitored using simple skin tests. In both the transfused patients and
the controls the mean DNCB score increased significantly from 4.8 to
6.8 (P < 0.001) and from 5.8 to 6.9 (P < 0.05), respectively. Anergic
patients tended to remain anergic, whereas the percentage of patients
with a strong response to DNCB increased after BT from 56% (27/48) to
67% (32/48). This increase was not significantly different compared to
that of the controls. The changes of the response to DNCB after S or 10
units of blood were not significantly different. Similar results were
observed using the 4 recall antigens. These results suggest that BT-
induced alterations in CMI cannot be assessed using sequential tests of
DTH. Anergic patients tend to remain anergic while strong responders
tend to give stronger response on repeating the tests in patients who
were sensitized to DNCB and recall antigens prior to any BT.
The influence of hemodiaffitration (HDF) on the T-lymphocyte trans-
formation. N. Lafi, A. Diamandopoulos, C.A. Gogos. G. Triantaphvl-
Iou, A. Apostolopoulos, P. Theothoropoulos, and N. Zoubos, Renal
Department and the University Laboratory of Haematology, Hospital
"Si. Andrews", Patras, Greece. T-lymphocytes from healthy volun-
teers were incubated with PHA and radioactive thymidine and the
amount of radioactive DNA was calculated. Later in the culture the
following were added: a) drainage fluid from the artificial kidney after
HD with cuprophan, of ten patients on chronic HD; b) drainage fluid
after HDF with polysulphone of nine patients on chronic HDF; c) the
same kind of fluid as (b) but from five patients on chronic HO who were
treated only once, on the day of the experiment, with HDF. We found
that the transformation of T-lymphocytes was suppressed: I) to 58.72%
by fluid, which mainly contained uremic toxins of small molecular
weight; 2) to 18.13%, P < 0.005 by fluid, which contained a very small
amount of either small or middle molecular weight toxins: and 3) to
87.8% (P < 0.001) by fluid, which contained large amounts of middle
molecular weight substances. We conclude that: The middle molecular
weight substances which can be cleared by a polysulphone filter are
mainly responsible for the suppression of 1-lymphocyte transformation
in uremia.
In vivo restoration of cell mediated immunity (CMI) by paired hemo-
diafiltration (PFD). A. Diamandopoulos, E. Hina,y, P. Theodoro-
poulos, and G. Triantaphvllou, Depart ,neni of Renal Diseases. Pairas
State Hospital "St. Andrews". The strength of the CMI of 12 healthy
volunteers and 27 CRF patients was estimated using the delayed
contact hypersensitivity dinitrochlorobenzene (D.N.C.B.) test. All the
patients were on chronic hemodialysis (HD) and had a significant
depression of CMI as compared with the controls (P < 0.0001). Later all
the HD patients were transferred to PFD and remained in this form of
treatment for four months. They were then re-checked with D.N.C.B.
We found a very significant increase of the strength of their CMI. which
returned to normal. This finding which is reported for first time
indicates that: a) the efferent and not the afferent branch of CMI is
damaged in uremic state; b) the more efficient blood purification with
PFD normalizes the CMI of renal patients.
In vitro improvement of the strength of cell mediated immunity (CMI)
by paired hemodiafiltration (PFD). C.A. Gogos. N. Zoubos. A. Aposto-
lopoulos, P. Theothoropoulos, N. Lafi, G. Triantaphvllou, E. Hinaiy,
and A. Diamandopoulos. Renal Department and the University Labo-
ratory of Haematology, Hospital 'St. Andreu's". Patras. The influence
of PFD over various T-lymphocyte subpopulations of ten renal patients
was estimated using the following methods: a) estimation of the total.
helper (T4) and suppressor (T8) T-lymphocytes; b) estimation of the
T4±/T8* ratio; c) estimation of the natural killer cells (N.K.) and their
activity. All the above were calculated while the patients were on HD
and also twenty and forty days after commencing PFD. The following
results were found: a) suppression of both total (61.85 35.6) and
helper T-lymphocytes (37.13 2.18) as compared with the control
group (64.65 2.39) P <0.10 and (46.62 1.97) P <0.05, respectively.
With PFD an increase was found of both total (65.55 4.10), P < 0.005,
and helper (45 3.0) P < 0.005 1-lymphocytes. Suppressor cells and
N.K. remained unchanged. N.K. activity increased but due to the small
number of patients this was not statistically significant. We concluded
that PFD improves the depressed CMI of uremia.
Comparative evaluation of chronic hemodialysis (CH) and CAPD: A
four year experience. G. Papadakis, D. Galanis, M. Siakotos, N.
Nikolopoulou, G. Metaxatos, P. Magana, N. Tsianas, G. Staugianou-
dakis, A. Drouzas, and A.G. Bulls. Division of Nephrology, "Evange-
lismos" Hospital. Athens, Greece. CAPD has been established in the
last few years as an alternative and often as a preferable to CH
technique, but until now there are in our country no comparative data
on the survival and physical rehabilitation of the patients (pts). Hence,
we have retrospectively studied 198 pts (114 males, 84 females), 19 to 78
years old (mean age 61.6 years) who started CH from June 1983 to May
1987 (group 1) and 60 pts (36 males, 24 females), 19 to 82 years old
(mean age 54.8 years). who started CAPD over the same period (group
II). Compared to group I, group II included significantly more pts aged
over 60 (32% and 47% respectively, P < 0.05), with diabetes mellitus
(3.5% and 13.6% respectively, P < 0.01) and cardiovascular problems,
such as severe hypertension (diastolic B.P. >120 mm Hg), coronary
disease and/or cardiac failure (29% and 55%, respectively, P < 0.001).
The follow-up period, which extended till the cessation or the change
(for medical reasons) of the original mode of treatment or until
December 1987, was 22.9 13.4 months for group I and 19.9 13.8
months for group 11 pts (P> 0.05). At the end of the follow-up period,
there were no statistically significant differences (P > 0.05) between
groups I and II: I) In the percentage of pts who were still on the initial
treatment (60.6% and 50%, respectively), or had stopped it because of
renal transplantation or improvement of their renal function (12.6% and
15%, respectively), or had changed mode of dialysis treatment (5.5%
and 5%. respectively), or had died (2 1.3% and 30%, respectively). 2) In
the 4-year cumulative survival rate (calculated by the Cutler-Ederer
method. 1958), which was 57% and 53%, respectively. 3) In the
percentage of pts with cardiovascular problems (42% and 43%, respec-
tively), 3) In the percentage of pts with cardiovascular problems (42%
and 43%. respectively) and 4) In the percentage of pts who were: a) able
to work (43% and 57%, respectively, b) unable to work, but capable to
look after themselves (48% and 33%, respectively) c) incapable to look
after themselves (9% and 10%. respectively). These results support the
prevailing view that the survival and physical rehabilitation of the pts
undergoing CAPD is favorably compared to that obtained with CH, and
that this is also true for pts who are elderly or have severe cardiovas-
cular problems.
The diagnostic, prognostic and therapeutic value of the renal biopsy in
acute renal failure. D. Galanis, Gr. Vosnides, F!. Sotsiou, M. Siakotos,
N. Niko!opoulou, S. Christodoulides, A. Poulopoulos, L. Marinos, N.
Tsianas, and AG. Billis, Division of Nephrology and Laboratory of
Pathology, 'Evangelismos' Hospital, Athens, Greece. in the last few
years there has been a controversy about the placement of renal biopsy
in patients who have acute renal failure (ARF). For this reason, we
retrospectively studied the diagnostic, prognostic and therapeutic value
of this technique in 52 patients (pts), 17 to 74 years old, with oliguric
(18) and non-oliguric parenchymal ARF who underwent renal biopsy
from 1-3-80 to 31-8-87 in order to diagnose (10 pts) or confirm the
clinical diagnosis (42 pts) of the underlying nephropathy. The biopsy
(percutaneous in 50 and open in 2 pts) which was done with a serum
creatinine of 3 to 22 mg% (mean value 9.8 mg%). disclosed glomerular
lesions in 27 (52%), acute tubulointerstitial nephropathy in 18 (34.5%)
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and vascular lesions in 7 (13.5%) pts. The histological study: I)
established the diagnosis in 16 pts(3l%), that is, in the 10 pts for whom
there was no clinical diagnosis and in 6 of the remaining 42 pts where
the histological diagnosis was significantly different from the clinical
one; 2) contributed definitely to the choice or modification of the
treatment in 24 pts (46%) and in the determination of the long-term
prognosis of the renal lesion, such as in the temporary or permanent
need of dialysis treatment in the 27 pts (59%) who were undergoing it.
Complications of the biopsy were unilateral nephrectomy in I Pt with
malignant hypertension and prolonged anuria and a perinephric ab-
scess, which was treated conservatively, in another pt. These observa-
tions suggest that, in parenchymal ARF, renal biopsy offers consider-
able help to establish or confirm the diagnosis, select the most
appropriate treatment and determine the prognosis, but it should be
done in pts selected by strict criteria.
Study of hemodialysis leucopenia 2. Comparison of changes in the
absolute number of different types of white blood cells with the use of
cuprophan and hemophan. K. Virvidakis, N. Tsagarakis, A. Fountou-
lakis, I. Tzanakis, and G. Sideras, Artificial Kidney Unit and Blood
Bank, Chania General Hospital. The object of this study was to
investigate the influence of different types of membranes in hemodial-
ysis leucopenia. We proceeded in this by evaluating the total number of
white blood cells and the absolute number of neutrophils, lymphocytes,
monocytes and eosinophils before the hemodialysis and IS, 30, 60, 120,
240 minutes after the beginning of hemodialysis in 14 patients with
end-stage renal failure. In all 14 patients (7 men and 7 women) we first
used cuprophan membrane, and then the study was repeated using
hemophan membrane. The decrease in the number of white blood cells
was significantly less in IS and 30 minutes when hemophan membrane
was used (P < 0.001 and P < 0.01, respectively); in the case of
hemophan rebound phenomenon was not observed in 120 and 240
minutes. The absolute number of neutrophils and monocytes decreased
significantly less in 15 and 30 minutes when hemophan membrane was
used, while there was no difference in the changes of lymphocytes and
eosinophils between the two membranes, In conclusion: I.) The hemo-
dialysis leucopenia is milder when hemophan membrane is used in
comparison to cuprophan. 2.) The differences between the two mem-
branes is due to the changes of neutrophils and monocytes.
Anaphylactoid reactions in hemodialysis (HO) patients. The importance
of antibodies against ethylene-oxide. A. Agrafiotis. D. Stamatiadis, G.
Bristoyannis, T. Zerva, Ch. Stathakis, A. Lagouranis, A. Katsarou, D.
Kiriaki, V. Alevizou, and Gr. Vosnides, Division of Nephrologv and
Department of Nuclear Medicine, Laiko General Hospital, Athens,
Greece. Anaphylactoid reactions at the onset of HD sessions have been
attributed to ethylene-oxide (ETO) sensitization. The present study was
undertaken in order to evaluate: I) the frequency of the presence and
the usefulness of the determination of anti-ethylene-oxide antibodies
(anti-ETO-abs) in pts undergoing HD; 2) the effect of the predialysis
extracorporeal circuit preparation on the occurrence of anaphylactoid
reactions due to ETO sensitization. The presence of anti-ETO-abs and
IgE levels were determined in the serum of 100 pts undergoing HD for
4 to 120 months, with cuprophan dialyzers (72 hollow fiber, 28 plate)
sterilized with ETO. Pre-dialysis rinsing of the extracorporeal circuit
was done with either 2.0 liter (60 pts) or with 0.5 liter (40 pts) of N.
saline. For comparison, 52 persons were used as controls, of whom, 12
were staff members of the HD unit for at least 13 months, 10 were ESRF
pts before commencement of dialysis (serum creatinine = 8.1 0.6
mg%) and, 30 were pts undergoing CAPD for at least 10 months.
Anti-ETO-abs were determined by radioallergo-sorbent test (RAST)
and IgE levels by RIA. Anti-ETO-abs were present in 3/52 (6%) of the
control group and in 22/100 (22%) of the HD pts (P < 0.005). Of the 22
HD pts with positive ETO abs. rinsing of the extracorporeal circuit was
done with 0.5 liter of normal saline in 14 and 2.0 liter in 8 (P < 0.005).
Anaphylactoid reactions were observed in 6/22 (27%) of the pts with
anti-ETO-abs and 6/78(8%) of the pts without anti-ETO-abs (P < 0.05).
No significant difference in serum IgE levels and blood eosinophil count
was found between the 22 HD pts with and the 78 HD pts without
anti-ETO-abs. The presence of anti-ETO-abs was not found to be
significantly affected by age, time on HD or type of dialyzer. The above
results indicate that: I) anti-ETO-abs are frequently found in HD pts; 2)
pts with anti-ETO-abs are more prone to anaphylactoid reactions; and
3) anti-ETO-abs develop more frequently when the pre-dialysis rinsing
of the extracorporeal circuit is inadequate. Thus, proper pre-dialysis
rinsing of the extracorporeal circuit may reduce the incidence of
anti-ETO-abs formation and subsequent anaphylactoid reactions.
Factors who determine serum ionized calcium concentration in ROT
patients. ND. Papa galanis, Photoula Stathoulopoulou, G. Tsoutakis,
Georgia Costogianni, A. Karabatsos, and!. Kimburis, Department of
Nephrology, General Hospital of Athens, Athens, Georgia. In order to
determine the main factors which determine serum ionized calcium
concentration in patients on RDT, Ca, P4, protein, HC03, PH, and
PTH were determined before and after one session of dialysis therapy
in 18 pts, on RDT. Linear with two predictor variable analysis showed
that serum ionized calcium concentration was positively correlated to
serum protein concentration (r = 0.48, P < 0.05) and negatively
correlated to serum bicarbonate concentration (r =
—0.74, P < 0.001)
postdialysis. Blood PH on the other hand negatively influenced serum
ionized calcium concentration either pre- or postdialysis. (r = —0.72, P
<0.001 and r = —0.59. P < 0.01, respectively). These results indicate
that patients who have the ability to metabolize acetate to bicarbonate
sufficiently, have higher serum ionized calcium concentration.
The significance of factors that determine serum ionized calcium
concentration for dialysis-induced hypotention. ND. Papagalanis, G.
Tsoufakis, F. Stathoulopoulou, A. Karabatsos, G. Kostogianni, G.
Moustakas, N. Afendakis, A. Karajiannis, C. Platsakis, and P. Ziro-
yiannis, Department of Nephrology. General Hospital of Athens,
Athens, Greece. To indentity the significance of serum ionized calcium
concentration for the dialysis-induced symptomatic hypotention, serum
total and ionized Ca bicarbonate protein, P4 concentration and blood
PH were determined in 6 pts with increased frequency of hypotention
during dialysis (group A) and in 12 pts with good adaptation to volume
reduction by ultrafiltration (group B). Blood PH and HC03 concen-
tration were lower in group A pts either pre- and postdialysis (P < 0.05)
and protein-concentration increased significantly only in this group of
pts postdialysis (P < 0.01). Serum ionized calcium concentration was
high in group A either pre- (1.16 0.09 mmol/liter vs. 0.9 0.03 mmol/
liter, P < 0.05) or postdialysis (1.4 0.09 mmol/liter vs. 1.13 0.06
mmol/liter, P < 0.05). The frequency of dialysis-induced hypotensive
episodes was positively correlated to serum ionized calcium concentra-
tion pre- (r = 0.5. P < 0.05) and post—(r = 0.46, P < 0.05) dialysis.
These results indicate that pts with dialysis induced hypotention may
have higher levels of serum ionized Ca due to faulty metabolism of
acetate to bicarbonate, and that this high Ca' concentration prevents
the increase of peripheral resistance during blood volume reduction by
ultrafiltration.
The effect of dialysate calcium concentration to the peripheral resis-
tance in vessels contractility during hemodialysis. N.D. Papagalanis, G.
Tsoufakis, A. Karahatsos, F. Stathoulopoulou, G. Kostogianni, H.
Kerahellia, G. Moustakas, N. Afendakis, K. Platsakis, and P. Ziro-
viannis, Nephrologv Department, General Hospital of Athens, Athens,
Greece. To examine the influence of calcium concentration in the
dialysate to the peripheral resistance in vessels, dialysate calcium
concentration was reduced from 3.34 mEq/liter to 3.0 mEq/liter for 3
months in six pts with increased frequency of dialysis-induced hypo-
tensive episodes, and it was increased from 3.34 mEq/liter to 3.76 mEq/
liter in five pts with controllable Hypertention, for 3 months. Although
BP levels showed no significant change during the period with dialysate
calcium modification either pre- or postdialysis in both hypertensive
and hypotensive pts, the frequency of dialysis-induced hypotensive
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episodes was reduced appreciably (from 0.61 0.6 episodes/dialysis/
month to 0.43 0.3 episodes/dialysis/month, t = 2.47, P = 0.05) in pts
with the problem. These results indicate that ionized calcium plays an
important role to the reactivity of resistance vessels of patients on RDT.
Manometric evidence of esophageal dysfunction in patients with
chronic renal failure. K.C. Siamopoulos, M. Dardamanis, G. Lagos, K.
Berekos, and E.B. Tsianos, Department of Nephrology and University
Department of Gastroenterology, G. Hatzikosta" General Hospital of
loannina, Greece. Abnormal esophageal motility has been reported in a
small group of chronic hemodialysis patients with symptoms of esoph-
ageal disease (Lancet i:219, 1984). We undertook the present study to
define the incidence and the type of esophageal dysmotility in 45
asymptomatic chronic uremic patients. Twenty-one of them had ad-
vanced chronic renal failure (CRF) and serum creatinine 7.8 2.4 (
SD) mg/dl, 17 patients were receiving chronic hemodialysis (CHD) for
39 (2 to 99) months and 7 patients were on CAPD for 7.4 (2 to 13)
months. None of them were diabetic or alcoholic and there was also no
evidence of other systemic disease or intestinal pseudo-obstruction.
Esophageal motility was investigated in our patients as well as in 25
normal controls by manometry. In addition, the presence of peripheral
neuropathy by motor nerve conduction measurements in the peroneal
and median nerves was also studied in our patients. Esophageal
dysmotility including triphasic tertiary constructions, frequent non-
peristaltic constructions, low applitude constructions during dry swal-
lows and hypertensive esophagus, was found in 9 (53%) patients with
CRF, in 8 (47%) patients on CHD and 2 (28%) patients on CAPD (22%
of patients had more than one abnormalities). Peripheral neuropathy
was found in 50% of patients. In patients with esophageal dysmotility.
peripheral neuropathy was found in 44%, 62% and 50% for groups CRF.
CHD and CAPD, respectively. In conclusion, esophageal dysmotility is
a frequent subclinical complication of severe chronic renal failure.
possibly due to esophageal nerves' lesions.
Comparative study of the gastritis of uremic and non-uremic patients in
correlation with the existence of CP. C/i. latroti, V. Delis, A. Menus, Lili
Mavromati, Ch. Spiliadis, A. Bleta, Z. Manika, P. Ziroyannis, and N.
Skandalis, Nephrology Department, Gastroenterology Department,
and Pathology Department, General Hospital of Athens: and Labora-
tory of Bacteriology, Hellenic Pasteur Institute, Athens, Greece. The
campylobacter pylon (CP) is a spiral shaped bacteria that possesses
urease and breaks urea. During the last 5 years its existence has been
associated with the antral gastritis in non-uremic patients (pts). The
purpose of this investigation was to study the frequency of CP in uremic
pts with gastritis in correlation with its frequency in non-uremic pts who
also had gastritis. In 29 uremic and 30 non-uremic pts with symptoms
from the upper gastrointestinal system they performed upper-GI-en-
doscopy and biopsy of the antral mucosa for istological study and
identification of CP. Identification of CP took place in tissue culture and
in istological smears with color according to Warthin-Starry. From the
29 uremic pts endoscopically 20 had gastritis and from 30 non-uremic
pts 18 had it. It was found that: a) the diagnosed percentage of
endoscopically found gastritis was about the same in the two groups of
pts (68.9% and 60%, respectively, P>0.l); b)the istological diagnosis
of gastritis in the two groups of pts was approximately the same, too
(82.76% and 86.67%, respectively, P> 0.1); c) the frequency of CF in
the two groups of pts did not differ significantly (87.5% and 92.3%.
respectively, P > 0.1). Conclusion: it appears that the frequency of
antral gastritis and the identification CF wasn't statistically significantly
different in both groups of patients.
Trace-element concentrations in peritoneal dialysis solutions used in
CAPD. A. Katirtzoglou, Th. Parade//is, N. Apostolidis, N. Mavopou-
lou-Symvoulidou, and Th. Mountokalakis, Second Medical Depart-
ment, University of Athens, Hippokration Hospital and TANDEM
Accelerator Laboratory, Nuc/ear Research Center De,nokritos Athens,
Greece. To determine whether peritoneal dialysis solutions used in
CAPD contain trace elements of possible biological significance, seven
solutions prepared by two different companies were analyzed by X-ray
fluorescence. The following trace elements were detected (concentra-
tion range in sg/liter): Cu 3-30, Zn 48-220, Br 160-220, Sr 14-56, Fe
<5-53. The presence of Br and Sr can be easily understood since these
elements are known to follow Ci and Ca chemistry. In contrast, the
origin of Cu and Zn remains unknown, although Zn was detected at
about 70 ppm in the plastic containers. Further studies are required to
determine whether the presence of Cu and Zn in the peritoneal dialysis
solutions has any influence on the metabolic balance of these elements
in patients treated by CAPD and/or on the function of peritoneal
membrane.
Long-term effect of buffer solutions (acetate-lactate) in the kinetics of
peritoneum in patients on CAPD. V. Vargemezis, V. Kilingis, P.
Pasadakis, P. Papaioakim, 0. Liamos, A.M. Belechri, and H. Thodis,
Division of Nephrology: Democritus University of Thrace G.H., Ale-
xadroupolis, Greece. The effect of buffers (acetate-lactate) on the
kinetics of the peritoneal membrane was studied for one year on three
groups of patients (N = 22) who were on CAPD. The first (A) group (N
= 7) had peritoneal solutions with acetate performed for 6 months,
while the second (B) (N = 7) lactate solutions were performed for the
same time. The third group of patients (C) (N = 6) used acetate
solutions for 6 months and changed to lactate, which were continually
performed for 12 months. Peritoneal clearances of urea and creatinine
(mI/mm), ultrafiltration (mi/exchange) and glucose absorption (g/ex-
change) were estimated at the beginning of the study and after 6 and 12
months as well (Table I). The results showed that: a) ultrafiltration was
significantly lower on group A (with acetate solutions) at the beginning
and at the end of both 6 month intervals. A significant increase in
ultrafiltration occurred in group C after changing the acetate to lactate
solution. This increase lasted 12 months. b) The absorption of glucose
was significantly higher in group A. c) There was not any difference in
the clearance of urea and creatinine during the study. In conclusion, the
solutions with acetate produce a reversible decrease of ultrafiltration,
while the clearances were not affected during the study.
Table 1.
Groups(m = months)
A
t = 0 6 m 12 m
Ultrafiltration 326 143 335 150 219 144
Abs. glucose 63 3 65 2 66 1
Cl. creatinine 19.9 3 19.6 1 19.2 I
B C
t=0 6m l2m t=0 6m 12m
722 154 670 126 456 92 283 115 547 150 601 106
60±1 61± 2 62±2 63±3 62± 2 62±2
18.3 5 18.9 4 18.1 4 19.0 3 18.9 6 18.8 4
The effect of calcium antagonists on the permeability of peritoneal
membrane in patients on CAPD. H. Thodis, V. Vargemezis, P. Pasa-
dakis. and G. Kabouro,niti, Division of Nephrology, Democritus Uni-
versity of Thrace G.H., Alexadroupolis, Greece. in clinical studies, the
effect of pharmacological agents on the efficacy of peritoneal dialysis is
usually correlated to the clearances' changes, while the mechanism
responsible for these changes is unknown, in this study the MTAC
(mass transfer area coefficient) was defined as a main index of perito-
neal membrane's permeability. Ten patients on steady CAPD state
were studied (5 men. 5 women, mean age 55.5 11.08 years), with
hospitalization for two successive days. All of them fasted without
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receiving antihypertensive or other cardiovascular medication. On the
first day, serum creatinine's level (r) and the concentration in the
dialysate effluent (Dr) were estimated, after an exchange of 2 liters of
1.5% in dextrose solution, with 4 hours dwell time. On the second day
the same exchange was repeated after the intraperitoneal instillation of
10 mg (5 mg/liter) verapamil. According to the transfer evaluation
protocol, MTAC was calculated before and after the administration of
the calcium antagonist, from the ratio (DiPr). The degree of creati-
nine's equilibrium increased from 67.573 14.92% to 78.712 9.33%
(P < 0.05), and the corresponding change in MTAC was from 10.456
3.37 mI/mm to 14.860 4.45 mI/mm (P < 0.05). Thus, the intraperito-
neal administration of calcium antagonists increased the permeability of
the peritoneal membrane in patients on CAPD. This effect is important
when the increase of the dialysis efficacy is demanded and the quite low
MTAC is responsible for the appearance of symptoms of inadequate
dialysis.
Phosphatidyicholine increases ultrafiltration in CAPD patients. N.
Dombros, E. Balaskas, N. Savidis, A. Tourkantonis, and K. Sombolos,
PDU, 1st Department of Medicine, AHEPA Hospital and Renal Unit
G, Papanikolaou Hospital, Thessaloniki, Greece. We studied the effect
of phosphatidylcholine on ultrafiltration in 14 (9 female, 5 male) patients
aged 56.3 6.3 ( SD) years with end-stage renal failure undergoing
CAPD for 9.6 II SD) months. None of the patients had
ultrafiltration failure, or recent (<2 months) peritonitis. Following an
overnight exchange, a 4 hour, (2 liter 1.5% glucose) exchange was
performed in each patient on day one (control exchange). On day two,
under the same conditions, 250 mg of phosphatidylcholine were added
in the morning bag (study exchange). Ultrafiltration (ml), sodium and
potassium transfer (mEq) creatinine and urea mass transfer area coef-
ficient (mI/mm) and glucose transfer (mg/kg), as well as glucose absorp-
tion (%) were calculated in control and study exchanges. The results
showed a highly significant increase in ultrafiltration (—28 194.5 vs.
195.3 110.5, P < 0.001), sodium transfer (—9.4 25.6 vs. 40.3 IS,
P < 0.001) and potassium transfer (—6.10 1.5 vs. —7.07 1.6, P <
0.005) in the phosphatidylcholine containing exchanges. There were no
differences found in creatinine and urea mass transfer area coefficient.
Our data indicate that in CAPD patients with normal ultrafiltration the
addition of 250 mg of phosphatidyicholine into peritoneal dialysis
solution (2 liter) increases ultrafiltration.
The influence of omentectomy on peritoneal ultrafiltration (UF) in
rabbits. K. Sombolos, N. Dombros, G. Digenis, and D. Oreopoulos,
Peritoneal Dialysis Unit, Toronto Western Hospital, Toronto, Ontario,
Canada. The effect of omentectomy on peritoneal UF, during a 300 mm
peritoneal dialysis exchange, was studied in two groups of normal
female New Zealand rabbits. Group A (study group, N = 12 animals),
with a mean body wt of 2.36 0.24 kg, underwent omentectomy while
Group B (control group, N = 12), with a mean body wt of 2.37 0.16
kg, underwent a sham operation. Through a peritoneal catheter, pen-
toneal dialysis fluid (Dianeal 4.25% lactate) was infused at a dose of 50
mi/kg in both groups. Blood and peritoneal fluid samples at 0 and 300
mm were withdrawn for measurements of glucose (G), urea (U), sodium
(Na) and osmolality (Osm). At the end of the experiment(300 mm) the
animals were sacrificed and the final volume of peritoneal dialysis fluid
was completely collected throughout an extensive abdominal incision.
Ultrafiltration (ml/kg), 6 absorption (%), net Na transfer (mEq) and
urea mass transfer area coefficient (UMTAC mI/mm/kg) at 300 mm are
shown in the Table, for both groups SD).
Time
300 mm
UF
zml/kg
G Absor.
%
Na tran
mEq
sfer UMTAC
mI/mm/kg
Group A 26.9 4.6 75.6 7.0 —8.7 1.7 0.40 0.1
(N = 12)
Group B 21.1 4.8 81.0 4.9 —7.0 1.4 0.46 0.09
(N = 12)
At 300 mm. the UF was statistically significantly higher (P < 0.01), the
G absorption lower (P < 0.05) and Na transfer higher (P < 0.025) in
Group A as compared to group B. No significant differences were found
at 0 and 300 mm for G, Na and U concentrations and osmolality in blood
and penitoneal dialysis fluid between the two groups. We conclude that
omentectomy increases peritoneal ultrafiltration in rabbits at 300 mm,
probably by decreasing glucose absorption.
Persistent peritonitis in CAPD and the role of the imaging techniques in
its investigation. Ch. Iatrou, A. Karnyanis, G. Moustakas, J. Datseris,
Ch. Drossos, M. Tsouroulas, K. Platsakis, and P. Ziroyannis, Nephrol-
ogy Department, General Hospital of Athens, Athens, Greece. The
value of diagnosis of the imaging techniques [ultrasound (ECHO),
computed tomography (CT) and the radiogalium scanning (Ga-67 cit-
rate)) in the investigation of fever of unknown origin, in order to detect
the inflammatory foci in the abdominal area, is known. From these
three techniques, the Ga-67 citrate has not been used in the detection of
abscess in patients (pts) with persistent peritonitis who are subjected to
continuous ambulatory penitoneal dialysis (CAPD). In this study, all the
three imaging techniques were used in pts with persistent peritonitis
subjected to CAPD in order to: a) detect inflammatory foci which could
be incriminated for the persistent peritonitis; and b) the comparative
evaluation of the three techniques in the detection of inflammatory foci.
In five pts subjected to CAPD for a mean period of 34.5 months and had
persistent peritonitis, the possible existence of inflammatory foci was
studied by ECHO, CT and Ga-67 citrate. The examination with ECHO
and CT were negative for the detection of these foci in all five pts. On
the contrary, the Ga-67 citrate examination turned out to be positive in
three of them for the existence of inflammatory foci in the area of tunnel
or inside the peritoneal cavity. Conclusion: It seems that despite the
small number of pts who were studied, the Ga-67 citrate constitutes the
best imaging technique of detection of inflammatory foci in the CAPD,
in relation with the other two techniques.
Abdominal hernias in patients on CAPD: Decreased incidence after the
first year of treatment. T. Kakavoulis, B. Margellos, M. Siakotos, S.
Klimopoulos, G. Papadakis, N. Nikolopoulou, D. Moutzouris, G.
Metaxatos, A. Poulopoulos, and AG. Billis, Department of Medicine,
Division of Nephrology, "Evangelismos" Hospital, Athens, Greece.
Abdominal hernias occur in 10 to 25% of patients on CAPD, and it was
recently reported that the cumulative risk of their development in-
creases by approximately 20% per year of treatment. We studied this
problem in 81 patients (50 males, 31 females), aged 19 to 82 years, who
had undergone catheter insertion for CAPD from May 1983 to Decem-
ber 1986. The placement of the straight double-cuff Tenckhoff catheter
was done under local anesthesia through a vertical midline infra-
umbilical incision. In 6 patients (74%) a preexisting umbilical hernia was
found and repaired at the time of the catheter insertion without any
recurrence during the follow-up period. All patients had been followed
for at least 12 months or until the discontinuation of CAPD because of
death (27), renal transplantation (7), transfer to hemodialysis (9) or
recovery of the renal function (3). During the follow-up period (2 to 50
months). 14 patients (17%) developed 18 hernias (7 groin, 5 umbilical, 5
incisional, I epigastric) and twelve of them underwent surgical repair.
Thirteen of the 18 hernias (72%) developed during the first year of
treatment and the remaining five during the second year. Thereafter,
none of the 18 patients who were followed for 36 months developed
abdominal hernias. No correlation was found between hernias and sex,
age, obesity, diabetes or previous corticosteroid treatment; however,
six of these 14 patients had undergone abdominal operations for hernia
repair (3) or other disease. In conclusion, the incidence of abdominal
hernias in patients on CAPD in our patients, contrary to other reports,
was found to decrease significantly following the first year of treatment.
Trocar insertion of Tenckhoff catheter for intermittent peritoneal
dialysis (IPD) or CAPD. N. Nikolopoulou, D. Moutzouris, M. Siakotos,
B. Margellos, A. Poulopoulos, M. Rababa, N. Tsianas, M. Zavros, J.
Malegos, and AG. Billis, Department of Medicine, Division of
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Nephrology, "Evangelismos" Hospital, Athens, Greece. Insertion of
Tenckhoff catheter (TC) by trocar for peritoneal dialysis is a simple
technique, but experience till now seems limited. Between January 1986
and November 1987 we inserted by trocar TC in 30 patients (pts). 16
males and 14 females, 26 to 76 years old, for IPD (7 pts) or CAPD (23
pts). The straight teflon double-cuff TC was inserted under local
anesthesia via a trocar in the midline 2 cm below the umbilicus. The
presence of hernias was the sole contra-indication for the technique.
The placement of the catheter, which was taking place in a side ward of
the CAPD unit and lasted for about one hour. was successful and
without any complications (visceral or vessel injury, leakage of dialy-
sate, inadequate catheter function) in all pts, except one in whom the
initial catheter was replaced immediately after its insertion because of
kinking. In the 7 pts who underwent IPD, the catheter functioned
satisfactorily for the whole period (Ito 10 months) that IPD had to be
carried out. Also, the catheter functioned well in all 23 pts who were on
CAPD till the end of the follow-up period (Ito 23 months). No hernias
were observed and the only complications were infections at the exit
site in 2 pts and leakage of dialysate in I Pt. These complications, as
well the episodes of peritonitis (8 pts), were comparably fewer to those
observed in another group of 23 pts who were undergoing CAPD over
the same period by surgical catheter implantation. These observations
suggest that the insertion of TC by trocar is an easy to use, effective,
and moreover safe technique, with possibly fewer complications com-
pared to the surgical one.
Functional survival of CAPD catheters. T. Kakavoulis. B. Margellos,
G. Papadakis, M. Siakotos, D. Moutzouris, B. Xantjikonstantinou.
Chr. Christodoulidou, N. Nikolopoulou. D. Galanis. A.G. Billis, De-
partment of Medicine, Division of Nephrology. "Evangelismos" Hos-
pita!, Athens, Greece. Failure of CAPD catheter function requires its
replacement. This complication occurs in 50% of patients on CAPD
during the first year of treatment. In order to estimate the incidence of
catheter failure, we studied retrospectively 81 patients (50 males, 31
females), aged 19 to 82 years, who had undergone insertion of CAPD
catheter from May 1983 to December 1986. The placement of the
straight double-cuff Tenckhoff catheter was done under local anaesthe-
sia through a vertical midline infra-umbilical incision. Ninety-four
peritoneal catheters were placed in 81 patients who have been followed
for at least 12 months or until the discontinuation of CAPD (46 patients)
because of death (27), renal transplantation (7). transfer to hemodialysis
(9) or recovery of the renal function (3). Until the end of the follow-up
period (December 1987), 13 catheters had to be replaced in II patients
due to dislodgement (4). one-way obstruction (2). dialysate leak (2).
subcutaneous tunnel-tract infection (2). accidental cutting of catheter
(2), and abscess of abdominal rectal muscle (I). The remaining 70
catheters in 70 patients have satisfactorily functioned from 2 to 50
months. The cumulative survival of peritoneal catheter, calculated by
the Cutler-Ederer life-table method, was 86% at I year from starting
CAPD and 69% by the end of the 4th year. These observations suggest
that the percentage of the functional survival of CAPD catheter in this
series is satisfactory, compared to that reported in the literature.
F-system: In vitro study of a new CAPD line with double bag and
disinfectant. P. Anassis, G. Sakellariou, E. Tzamou, P. Koukoudis, A.
Sioudas, and M. Papadimisriou. 2nd Prop. Dept. f Internal Medicine,
Ippocration General Hospital, Aristotelian University f Thessaloniki,
Greece. The risk of peritonitis due to contamination in the connection
step of the bag exchange is still the most common problem of CAPD. In
order to ameliorate exogenous contamination a new CAPD line was
invented and constructed: The F-system. To evaluate the protective
role of F-system in CAPD peritonitis: I)ln a total of forty experiments.
pure cultures of pathogens (optical density io CFU/ml) were used as
inocula at the level of connector. After contamination the following
were performed: a) infusion of povidone-iodine 10% into F-system: b)
exchange of fluids between F-system and a sterile full-fluid bag ("ar-
tificial peritoneum"); c) tests of artificial peritoneum fluid for microor-
ganisms (cultures) or disinfectant (Starch reaction of 12). 2) In the other
ten experiments i's' (50 .cC) was mixed with Povidone-iodine. To test
the probability of mixing of peritoneum fluid with disinfectant, we
counted the amount of '-radiation of artificial peritoneum before and
after fluid exchange. Results from series I and 2 showed no positive
cultures (for ten days) and no mixing with disinfectant. It is concluded
that the F-system is highly efficient for preventing peritonitis caused by
bacteria or disinfectants, It is discussed the advantages of F-system in
accordance with y-systems.
Effect of a somatostatin analog (SMS 201-995) on renal function in
cirrhosis. N. Kallivretakis, D. Mayopoulou-Symvoulidou. G. Kar-
t'ountzis, G. To/is, and T. Mountokalakis, Second Medical Department,
University of Athens, Hippokration Hospital, Athens, Greece. Somato-
statin and its long-acting analog SMS 20 1-995 have been known to
produce a water diuresis in dogs by antagonizing vasopressin action.
We investigated the effect of iv. infusion of SMS 201-995 (at 40 cg/hr
for 2 hrs) on creatinine clearance (Ccr)m urine flow (V), urine osmolal-
ity (Uom) and urine Na excretion (UNV) in 9 patients, 4 men and 5
women, aged 53 to 65 years, with decompensated cirrhosis, normal
serum creatinine, low serum Na levels (l35 mEq/liter), and low V
(0.60 mI/mm). Any diuretic treatment was discontinued at least 10
days before study. Following SMS 20 1-995 infusion Cr increased from
(mean 5EM) 67.7 8.7 to 96.5 10.1 mI/mm (P < 0.05); V increased
from 0.42 0.04 to 0.76 0.08 (P < 0.001); and U0 decreased from
566.2 63.0 to 430.6 56.3 mOsm/kg. UNaV remained unchanged
(22.0 5.96 and 25.8 7.99 cEq/min). The renal effects of SMS
201-995 might be attributed to an inhibition of both the tubular (V2) and
the renal mesangial (V1) receptors of vasopressin, and might have
considerable implications in the treatment of renal abnormalities com-
plicating liver cirrhosis.
Renal tubular uric acid transport in type I diabetic patients with
hypouricemia. K. Paletas, 1. Magoula, G. Tsapas, K. Mavromatides.
V. Tzetzis, and G. Vis%'ardis. B' Medical Clinic Aristotelian University
of T/iessaloniki, Thessa/oniki. Greece. We studied 6 patients (5 women
and I men) from 18 to 21 years old (20.6 0.8 5EM), suffering from type
1 diabetes mellitus with normal renal function (Ccr: 108.51 mI/mm
12.26) and serum uric acid below 2.5 mg% (Sur: 2.23 mg% 0.13) as
well as a high uric acid clearance (Cur: 20.31 mI/mm 2.11) and
fractional urate excretion (FEur: 18.50 1.29) versus Cur: 9.75 mI/mm
1.65 and FEr: 9.90 1.90 in normal controls, respectively. The
study of the uricosuric mechanisms was conducted by the combination
of Probenecid test (which inhibits the postsecretory reabsorption of uric
acid) and Pyrazinamid test (which inhibits its tubular secretion). Our
results are summarized as follow: The presecretory reabsorbed uric
acid in the patients was 2795 .cg/min 157, 97.65% of the filtered
instead of 4546 g/min 879 and 99.06% in the normal controls,
respectively. The secreted uric acid in patients was 1429 cg/min 127
instead of 1832 sg/min 318 in controls. The postsecretory reabsorbed
was 969 cg/min 73.8, 67% of the secreted uric acid instead of 1471 gI
mm 191.3 and 80.29% in normal controls, respectively. From our
data we conclude that the high uric acid excretion in diabetics is due to
the partial inhibition of the presecretory reabsorption and of the
postsecretory reabsorption. In contrary, tubular secretion should not be
the cause of uricosuria because it was found even reduced, possibly as
a result of the low urate plasma levels.
Atrial natriuretic factor (ANF) and arginine vasopressin (AVP) during
conventional hemodialysis. K. Soinpolos, K. Kalogerus, M. Pagalos. A.
Ka/ogera, P. Gold, and G. Chrou.cos, Renal Unit, G. Papanikolaou"
General Hospital, Thessaloniki. Greece and BPB National Institute of
Mental Health, Bethesda. Maryland, USA. Plasma concentrations of
ANF and AVP was measured by radioimmunoassay (RIA) in 10 chronic
dialysis patients (4 males. 6 females, median age 55 (28 to 70] years),
before (0) and after (4 hours) a conventional hemodialysis session.
Glucose free dialysate with a sodium concentration of 142 mEq/liter
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was used in all sessions. Mean values ( + sEM) for the body weight
(BW), mean arterial blood pressure (MAP), heart rate (HR) as well as
ANF and AVP plasma concentrations in all patients, before and after
the session are shown in the Table.
BW
kg
MAP
mm Hg
H;
mm
AVP ANF
pg/,nl
0 68.4 2.4 109.6 5.4 75.6 3.8 60.5 9.9 3.6 0.4
4 hrs 66.5 2.4 94.3 6.3 81.8 5.9 32.2 6.8 4.3 1.1
Pair t P < 0.001 P < 0.02 NS P < 0.02 NS
Plasma concentrations of ANF after the hemodialysis session, de-
creased significantly (P < 0.02) while AVP concentrations did not
change. We didn't find any statistically significant correlation between
changes in ANF plasma concentrations and changes in BW or MAP
after the session. We conclude that during a 4-hour conventional
hemodialysis session, ANF plasma concentrations decrease signifi-
cantly while AVP levels remain unchanged.
Erythrocytes ferritin as iron deficiency index of hemodialyzed patients.
J. Papadakis, A. Germenis, N. Miariti, A. Patrikarea, K. Politi, and S.
Vafiadis, Rena! Department of NIMTS Hospital and T/ialassaemia
Unit of Hellenic Red Cross Hospital, Athens, Greece. Iron deficiency
(ID) is an additional cause of anemia in uremic hemodialyzed patients(HP). However the estimation of ID in HP for iron (Fe) deficit
replacement with the conventional hematological parameters (serum
Fe, erythrocytes indices, total iron binding capacity (TIBC]) isn't
usually, definitive. In addition serum ferritin (SF), that is considered as
a reliable index of ID. was found much higher than normal in our
anemic HP. So we studied whether the erythrocytes ferritin (EF) is a
more reliable index of ID in HP. In 15 HP of mean age 54 years (31 to
79) with considerable anemia, hemoglobin (Hb) 8.01.2 g/dl. i.v. Fe
was given in a dose that was estimated from their body weight and Hb.
Before and 3 weeks after the Fe administration the Hb. MCH. MCV.
serum Fe, TIBC, SF and EF were measured. SF and EF were measured
by immunoenzymatic method. Twenty-four healthy persons, of the
same sex and mean age, were used as controls. Five patients responded
(R) to the Fe, with a mean increment of Hb by 2.9 g/dl. SF (zg/liter),
before the Fe administration, in the R (363.7 52.2) as well as in the
non-responders (NR) (206.7 43.2) was significantly higher (P < 0.001)
from the controls (42 13.4). At the same time EF (g/gHb) of R (60.3
8.5) was significantly lower (P < 0.001), while the EF of NR (418.3
54.7) was not different from the EF of the controls (385.2 56.4). After
the Fe administration the EF increased very significantly in both
groups, R = 189.6 72.1 (P <0.01) NR = 952.0 124.3 (P < 0.001).
while the SF increment was less significant. R = 493.2 101.4 (P <
0.05) NR = 278.2 61.3 (P < 0.02). The mean values of the other
hematological parameters, before and after the i.v. Fe administration,
were in the normal limits. We conclude that, in contrast with SF. the EF
can be considered as an excellent index of iron deficiency of uremic
hemodialyzed patients.
Correlation of glycosylated hemoglobin with uremia. K. Mar roma-
tidis, S. Spaia, K. Dimitrakopoulos, A. Uzuni. E. Bezazi—Papakonstan-
tinou, and G. Vavonas, Department of Internal Medicine-Rena! Unit.
2nd Hospital of IKA-Thessaloniki, Greece. We have studied the gi y-
cosylated hemoglobin (HBA,C) of 135 persons. Forty-three of them were
controls (group E) and the rest 92 were uremic. The uremic patients
were divided into four groups: Group A with 26 patients and serum
creatinine from 1.3 to 3 mg%. group B with 24 patients and serum
creatinine from 3.1 to 6 mg%. group C with 17 patients and serum
creatinine from 6.1 to JO mg%. and finally group D with 25 hemo-
dialyzed patients. Smokers, patients with cardiac and respiratory
failure, acute infection, diabetes mellitus and iron-deficiency anemia
were excluded from our study. The mean value of two samples, taken
during a four month interval, was used for the deterni nation of HBA1.
At the same time we measured serum urea, glucose, iron and creatinine.
Additionally, the value of PTH was determined in the hemodialyzed
patients. Results: The values of HBAC were in group E from 6 to 10.1%,
m.v. 8.02, in group A from 7.1 to 11.8%, m.v. 9.5, in group B from 6.7
to 13.7%, m.v. 9.9. in group C from 6.1 to 18.1 mg%, m.v. 12 and in
group D from 5.8 to 25.3%. m.v. 14.09. Conclusions: I.) The percentage
of HBAC increases proportionally to the degree of chronic renal failure.
2. The percentage of HBA1 does not increase proportionally when renal
failure is accompanied by massine proteinuria. 3. The percentage of
HBA, is not related to the primary disease. 4. There is a positive
correlation of HBAC with serum urea. 5. HBAI determination is a
helpful index to estimate the diet of uremic patients.
Vessel lesion in chronic unilateral pyelonephritis and their relation to
hypertension. N.D. Papagalanis, Helen Paraskevakou, E. Fokaeus, P.
Davaris, Georgia Kostogiani-Papagalani, A. Karabatsos, Annastasia
Tjonou, and N. Davi!!as. Histologic examination of blood vessels in
scarred and nonscarred areas of the affected kidneys from 20 patients
(pts) with chronic unilateral pyelonephritis was carried out. in addition
the correlation of PRA with the FEN + MBP, and patient's age was
examined, in an effort to identity the relationship between BP level,
scar process and renin-angiotensin system. Vascular changes were
greater in scarred than in the nonscarred areas, particularly in hyper-
tensive patients. Severe vascular changes in scars were seen only in
cases with hypertension. PRA was negatively correlated with MBP and
with patients age (r = —0.7, P < 0.05). Multiple linear regression
analysis. with the severity of vascular lesions as dependent variable and
the pts' age, sex. MBP, Cr, and PRA as independent variables, reveals
that age is the main factor which determine the severity of vascular
changes (P < 0.05) although the contribution of MBP must not be
ignored (P < 0.2). Linear with two predictor variable analysis reveals
pts' age to be the main factor which determine the level of MBP (r =
0.68. P < 0.05) and not the C level (r = —0.08). These results indicate
that the pyelonephritic process itself is an important factor in the
development of vascular changes: this effect, however, is influenced by
the BP level and most importantly, by age. They also indicate that the
renin-angiotensin system was not involved in the pathogenesis of
hypertension of these patients.
Left ventricular myocardial dysfunction in hypertensive patients with
end-stage chronic renal failure. J. Ivianolas, D. Valis, K. Papadopoulos,
L. K!avdianos, and A. Dontas, Diagnostic and Therapeutic Center of
At/tens Hvgia" S.A., Athens, Greece. In 46 consecutive hemo-
dialyzed patients with end-stage chronic renal failure, the systolic and
diastolic left ventricular (LV) function was evaluated using carotid
pulse and apex tracings. As indexes of LV systolic function served the
ratio of pre-ejection to ejection time (PEP/ET). whereas two relative A
wave height parameters (A/H and A/D) served as indexes of LV
compliance and two temporal apexcardiographic relaxation parameters
(TART and TARTI) as indexes of LV relaxation. Our patients were
divided in two groups: 13 patients were normotensive (group I) and the
other 33 patients had chronic systemic hypertension (group 2). in the
group I. only 2 patients (15%) had an abnormal PEP/ET (>0.42) and 4
patients (31%) had one or more apexcardiographic indexes of diastolic
LV function abnormal. In group 2. 22 patients (67%) had one or more
diastolic apexcardiographic indexes abnormal. Further. 10 of these
patients (45%) had both compliance and relaxation indexes abnormal.
In contrast, only 10 patients (30%) of group 2 had an abnormal PEP/ET.
whereas only 2 of them (20%) had also one or more diastolic indexes
abnormal. It is concluded that in hemodialyzed patients: I) LV dys-
function is more frequent in those with systemic hypertension: 2)
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diastolic LV dysfunction is more frequent than the systolic one: and 3)
diastolic and systolic LV dysfunction do often occur independently.
Urinary citrates in calcium stone disease. D. Mayopouloii-Sy,nvou-
lidis, Th. Mountokalakis, A. Katirtzoglou, Helen Diavidovitch-Consta,
A. Symvoulidis, Second Department of Internal Medicine, Athens
University, Hippocration Hospital, Athens, Greece. Urinary citrates
are considered significant inhibitors of calcium oxalate crystallization,
and in a number of patients hypocitraturia is referred as the sole or main
abnormality present. This study concerns the evaluation of the citrate
excretion in 24 hour urine, determined by enzymatic method (citrate
lyase) in 86 calcium stone patients (mean age 39.1, 49 men. 37 women)
and 21 controls (mean age 39.2, 12 men, 9 women). The 24-hour urinary
excretion of creatinine, uric acid, oxalates, K, Na, Ca, P and Mg was
also determined. Cases with urinary infection, renal tubular acidosis or
on diuretics were excluded from the study. No statistically significant
difference was found in the 24-hour citrate excretion between stone
patients and controls ( SEM mg/day, 344.6 27 vs. 332.4 44.6) nor
in the ratio urinary citrates/creatinine (0.271 0.025 vs. 0.264 0.037).
For the above parameters, a statistically significant difference was
found between men and women patients (286 25.7 vs. 414 49.7, P
<0.05 and 0.193 0.02 vs. 0.374 0.047, P < 0.001, respectively), but
not between men and women controls (317 69.8 vs. 355 50 and
0.230 0.055 vs. 0.346 0.05, respectively). It is concluded from our
study that the only difference found in 24-hour citrate excretion
concerned men and women stone patients.
